Kraj: Kanada
Język: angielski
Źródło: Health Canada
VITAMIN A (RETINYL PALMITATE); VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE)
NUTRICORP INTERNATIONAL
A11JA
COMBINATIONS OF VITAMINS
100000UNIT; 20UNIT
CAPSULE
VITAMIN A (RETINYL PALMITATE) 100000UNIT; VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) 20UNIT
ORAL
500
Prescription
VITAMIN A
Active ingredient group (AIG) number: 0225696006; AHFS:
APPROVED
2016-04-06
_ _ _Page 1 of 34_ PRODUCT MONOGRAPH PR VITAMIN A (100,000 IU) AND VITAMIN E (20 IU) ORAL LIQUID PREPARATION VITAMIN A AND VITAMIN E SOFTGEL CAPSULES 100,000 IU Vitamin A (all-trans-retinyl palmitate) and 20 IU Vitamin E (all-rac-alpha- tocopheryl acetate) One IU of Vitamin A is equivalent to the activity of 0.3 mcg of all-trans-retinol ATC code: Vitamins – A11 Nutricorp International 4025 Rhodes Drive Windsor, Ontario N8W 5B5 Date of Preparation: April 5, 2016 Submission Control No: 167923 _ _ _ _ _Page 2 of 34_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION .........................................................3 SUMMARY PRODUCT INFORMATION ........................................................................3 INDICATIONS AND CLINICAL USE ..............................................................................4 CONTRAINDICATIONS ...................................................................................................4 WARNINGS AND PRECAUTIONS ..................................................................................4 ADVERSE REACTIONS ....................................................................................................5 DRUG INTERACTIONS ....................................................................................................6 DOSAGE AND ADMINISTRATION ................................................................................7 OVERDOSAGE ..................................................................................................................8 ACTION AND CLINICAL PHARMACOLOGY ..............................................................9 STORAGE AND STABILITY ..........................................................................................12 DOSAGE FORMS, COMPOSITION AND PACKAGING .............................................12 PART II: SCIENTIFIC INFORMATION ...............................................................................14 PHARMACEUTICAL INFORMATION ....................................................... Przeczytaj cały dokument